Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol., 16 January 2026

Sec. Microbial Immunology

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1701722

This article is part of the Research TopicAdvancing Enteric Disease Treatments: Probiotics and Antimicrobial StrategiesView all articles

Effects of Lactobacillus plantarum ZG-7 on the intestinal barrier and intestinal flora of Muscovy ducks infected with avian pathogenic Escherichia coli

Song PengSong Peng1Bilin XieBilin Xie2Guiheng MeiGuiheng Mei3Yaxiong MaYaxiong Ma4Xin LinXin Lin3Mengshi ZhaoMengshi Zhao1Fengqiang LinFengqiang Lin1Zhaolong Li*Zhaolong Li1*
  • 1Institute of Animal Husbandry and Veterinary Medicine of Fujian Academy of Agricultural Sciences, Fuzhou, China
  • 2Putian Institute of Agricultural Sciences, Putian, China
  • 3Key Laboratory of Animal Pathogen Infection and Immunology of Fujian Province, College of Animal Sciences, Fujian Agricultural and Forestry University, Fuzhou, China
  • 4Key Laboratory of Traditional Chinese Veterinary Medicine and Animal Health in Fujian Province, College of Animal Sciences, Fujian Agriculture and Forestry University, Fuzhou, China

Introduction: Avian pathogenic Escherichia coli (APEC) poses a serious challenge to global poultry production, where it causes enteritis, septicemia, and high mortality, resulting in substantial economic losses. Although antibiotics have been traditionally used to control APEC, the rise of antimicrobial resistance and concerns over drug residues underscore the need for effective and sustainable alternatives. Probiotics have emerged as promising candidates because of their ability to modulate the intestinal microbiota, strengthen host immunity, and preserve epithelial barrier integrity. In this study, we investigated the protective role of Lactobacillus plantarum ZG-7 against APEC infection in Muscovy ducks.

Methods: 40 one-day-old ducks (equal numbers of males and females) were randomly allocated to five groups (n = 8 per group): control (CON), probiotic alone (LP), APEC-infected (EC), probiotic-pretreated APEC-infected (LPEC), and colistin sulfate-treated APEC-infected (CSEC), with the latter serving as a positive control and exhibiting expected protective effects. On day 7, ducks in the EC and LPEC groups received two oral doses of pathogenic E. coli O78 (3 × 10^9 CFU/mL, 0.2 mL) at an 8-hour interval, while ducks in the CON and LP groups received sterile saline. Serum and intestinal samples were collected on day 15.

Results: APEC infection significantly reduced average daily gain during days 9–15 and across the trial. Histopathological analysis showed epithelial disruption, crypt and gland loss, reduced goblet cells, diminished mucus secretion, and decreased expression of tight junction proteins (ZO-1, MUC2, Occludin). In contrast, L. plantarum ZG-7 treatment alleviated intestinal injury and restored growth performance. 16S rRNA sequencing further revealed that APEC challenge increased the abundance of unclassified Lachnospiraceae, Lachnoclostridium, norank RF39 group, and Paludicola (P < 0.05), whereas L. plantarum ZG-7 treatment reduced these taxa. Moreover, probiotic supplementation alone significantly enriched Bacteroides (P < 0.001).

Discussion: Taken together, these results demonstrate that L. plantarum ZG-7 helps maintain a beneficial microbial composition, protects epithelial barrier function, and mitigates the adverse effects of APEC infection in Muscovy ducks, highlighting its potential as a natural and sustainable alternative for improving poultry health.

1 Introduction

Avian pathogenic Escherichia coli (APEC) is widely recognized as the principal etiological agent of colibacillosis in poultry, a condition that seriously compromises flock health and production efficiency worldwide (1). Beyond inducing both systemic and localized infections that impair immune competence, APEC also undermines the intestinal epithelial barrier and disrupts gut microbial ecology. Ducks are particularly vulnerable hosts, often exhibiting progressive weight loss, weakness, and eventually systemic failure followed by death. Studies have shown that APEC attaches to intestinal epithelial cells via fimbrial and non-fimbrial adhesins, facilitating colonization and barrier disruption. This process increases epithelial permeability, enabling bacterial translocation into the bloodstream, where diverse virulence factors provoke widespread inflammatory responses (2). In addition, APEC challenge commonly results in dysbiosis, characterized by the overgrowth of pathogenic taxa and the reduction of beneficial commensals. The conventional strategy for controlling colibacillosis has been antibiotic intervention, typically with agents such as colistin sulfate or enrofloxacin (3). However, the growing prevalence of antimicrobial resistance, along with concerns about drug residues in animal products, has eroded confidence in antibiotic-based approaches and highlighted the need for new, sustainable solutions.

Probiotics are generally defined as live microorganisms that, when administered in adequate amounts, confer health benefits to the host (4). Their biological functions extend beyond simple colonization and include reinforcement of epithelial barrier integrity, competitive exclusion of pathogens, production of antimicrobial metabolites, and modulation of host immune responses. These properties make probiotics attractive candidates for the prevention and management of bacterial infections. Among them, Lactobacillus plantarum is a highly versatile lactic acid bacterium that occurs widely in diverse ecological niches, including vegetables, fruits, legumes, dairy and meat products, and beverages, as well as in mucosal environments of humans and animals such as the oral cavity, gastrointestinal tract, and reproductive tract (5). Due to its broad physiological capabilities and well-documented health-promoting properties, L. plantarum has been extensively applied in the food industry, clinical practice, and animal production.

Accumulating evidence has demonstrated the beneficial effects of L. plantarum on intestinal health. Oral supplementation has been shown to increase the ratio of Firmicutes to Bacteroidetes, enhance microbial diversity, suppress pathogenic bacterial activity, and ameliorate colitis-associated dysbiosis in mice (6). In TNBS-induced colitis, L. plantarum LC27 upregulated the expression of tight junction proteins, decreased serum aminotransferase activity, and reduced the relative abundance of Proteobacteria and Bacteroidetes, thereby restoring intestinal homeostasis (7). In poultry, dietary L. plantarum B1 supplementation improved growth performance, reduced cecal Escherichia coli counts, increased Lactobacillus abundance, and enhanced intestinal mucosal immunity in broilers challenged with E. coli K88 (8). Likewise, administration of L. plantarum LP-BL0111 markedly decreased diarrhea scores in broilers, modulated gut microbial composition, and strengthened mucosal barrier function, leading to a significant attenuation of Salmonella-induced intestinal injury, with improvement rates reported up to 86.45% (9).

Our previous work further demonstrated that the culture supernatant of L. plantarum ZG-7 exerted potent inhibitory effects against Riemerella anatipestifer by disrupting membrane integrity, thereby suppressing bacterial proliferation (10). These findings, together with extensive evidence from other L. plantarum strains, suggest that targeted probiotic supplementation can help establish beneficial microbial communities, preserve intestinal homeostasis, enhance epithelial barrier integrity, and support host growth and immune function. Consequently, L. plantarum has attracted considerable attention as a natural alternative for improving poultry health and mitigating bacterial infections.

Despite these advances, the strain-specific probiotic effects of L. plantarum in waterfowl—particularly Muscovy ducks, which are highly susceptible to APEC—remain insufficiently characterized. Furthermore, no studies have evaluated whether a naturally fermented-food–derived L. plantarum strain can protect ducks from APEC-induced intestinal injury. Given that ZG-7 has previously shown potent inhibitory activity against the Gram-negative pathogen R. anatipestifer, which shares key outer-membrane features and mucosal injury patterns with APEC, we hypothesized that ZG-7 may possess broader antagonistic potential against Gram-negative enteric pathogens. Specifically, we proposed that ZG-7 could alleviate APEC-induced gut injury by enhancing mucin and tight-junction protein expression and by modulating the cecal microbiota. Therefore, this study was designed to elucidate the strain-specific protective mechanisms of L. plantarum ZG-7 using an APEC-infected Muscovy duck model.

2 Materials and methods

2.1 Isolation and purification of bacterial strains

Lactobacillus plantarum ZG-7 was originally isolated from naturally fermented pickles collected from a village in Fujian Province, China. The fermentation process was carried out under natural conditions without the addition of starter cultures. The strain was deposited in the China General Microbiological Culture Collection Center (CGMCC, accession no. 7370). Bacteria were isolated from the pickle samples following previously described protocols with minor modifications. Briefly, solid samples were chopped and mixed with sterile phosphate-buffered saline (PBS), and the mixture was homogenized using a blender (Saivier, Wuhan, China). The homogenates were vortexed vigorously, plated onto de Man–Rogosa–Sharpe (MRS) agar (Haibo, Qingdao, China), and incubated anaerobically at 37°C for 48 h. Colonies were subcultured at least three times until purified isolates were obtained. For preparation of bacterial suspensions, cells were harvested by centrifugation at 3000 rpm for 10 min at 4°C, and the pellets were washed and resuspended in sterile saline to a final concentration of 1 × 10^9 CFU/mL. Strain identification was performed by 16S rDNA sequencing. Genomic DNA was extracted using a commercial bacterial genomic DNA extraction kit (Ezup Column, Sangon Biotech, Shanghai, China). The 16S rRNA gene was amplified by PCR, purified, and sequenced by Shanghai Sangya Biotechnology Co., Ltd. Viable cell counts of ZG-7 were quantified by spread-plating 10-fold serial dilutions onto MRS agar and incubating at 37°C for 24 h to ensure a final concentration of 2 × 10^9 CFU/mL for oral administration. All bacterial suspensions were freshly prepared for each experiment. If short-term storage was required (< 2 h), the suspensions were kept at 4°C in the dark, and viability was confirmed at 0, 2, and 4 h to ensure stability (>95% of the initial CFU).

2.2 Acid and bile salt tolerance assays

To evaluate the acid and bile tolerance of Lactobacillus plantarum ZG-7, overnight cultures were prepared in sterile MRS broth (Haibo, Qingdao, China) at 37°C. Cells were harvested by centrifugation (3000 rpm, 10 min, 4°C), washed twice with phosphate-buffered saline (PBS), and resuspended in fresh MRS broth. For acid challenge assays, bacterial suspensions were diluted 1:100 in MRS broth adjusted to pH 2.0, 3.0, or 4.0. Bile salt tolerance was determined by inoculating suspensions into MRS broth supplemented with 0.1%, 0.3%, 0.5%, or 1% (w/v) bile salts (Yuanye Biotechnology Co., Ltd., Shanghai, China). All cultures were incubated at 37 °C with agitation at 150 rpm. Bacterial survival and growth under acidic or bile salt conditions were monitored exclusively by measuring optical density at 600 nm (OD600) at 0, 6, 12, 18, and 24 h. OD600 values served as indicators of ZG-7 proliferation and tolerance under each stress condition.

2.3 Antibacterial activity of Lactobacillus plantarum

The antibacterial activity of the cell-free supernatant of Lactobacillus plantarum ZG-7 against avian pathogenic Escherichia coli O78 was assessed using the Oxford cup assay. The O78 strain was obtained from the Institute of Animal Husbandry and Veterinary Medicine, Fujian Academy of Agricultural Sciences (FAAS, China). ZG-7 was cultured in MRS broth for 24 h, and the culture was centrifuged at 10,000 rpm for 5 min. The supernatant was filtered through a 0.45 μm membrane, and a portion was adjusted to pH 7.0 to serve as the control (CON). The pathogenic strain was spread on LB agar plates, and Oxford cups were placed on the surface. The wells were filled with ZG-7 supernatant at concentrations of 1 × 10^8 CFU/mL and 1 × 10^9 CFU/mL. Plates were incubated at 37°C for 8 h, after which inhibition zones were measured.

2.4 Animal experiment

A total of 40 healthy one-day-old Muscovy ducks (equal numbers of males and females) were obtained from Zhangzhou Changlong Animal Husbandry Co., Ltd. (Fujian, China) and randomly allocated into five groups of equal initial body weight. Randomization was performed using a random-number table to ensure unbiased allocation of animals to experimental groups. All birds were housed separately under identical conditions and fed a basal diet. Ducks were reared in two-tier wire cages with ad libitum access to feed and water. The lighting schedule consisted of 24 h continuous light from days 1 to 7, followed by 23 h light/1 h dark thereafter. Room temperature was maintained at 32°C during the first week and gradually decreased to 25°C by day 15. No antibiotics, coccidiostats, or other microbiota-altering agents were administered throughout the experiment. A corn–soybean basal diet was formulated according to the nutritional recommendations of the National Research Council (NRC, 1994) and the Chinese Feeding Standard for Meat Ducks (NY/T 2122-2012) to meet the nutrient requirements of Muscovy ducks. The composition and nutrient levels of the basal diet are provided in Supplementary Table 1.

The control group (CON) received PBS without E. coli O78 challenge; the infection group (EC) received PBS and was orally challenged on day 7 with two doses of E. coli O78 suspension (3 × 10^9 CFU/mL, 0.2 mL each) administered 8 h apart; the probiotic group (LP) was administered 0.5 mL of Lactobacillus plantarum ZG-7 (2 × 10^9 CFU/mL) daily; the probiotic + challenge group (LPEC) received the same probiotic treatment daily and was orally challenged on day 7 with two doses of E. coli O78 suspension (3 × 10^9 CFU/mL, 0.2 mL each) administered 8 h apart; and the colistin + challenge group (CSEC) was administered 0.5 mL of colistin sulfate solution (200 mg/mL) daily and was orally challenged on day 7 with two doses of E. coli O78 suspension (3 × 10^9 CFU/mL, 0.2 mL each) administered 8 h apart. The experimental workflow is illustrated in Figure 1. All histopathological evaluations (HE, AB-PAS, immunofluorescence) and microbial analyses were conducted by independent investigators who were blinded to the treatment groups throughout the study.

Figure 1
Diagram showing treatment schedules for five groups of ducks: CON, LP, EC, LPEC, CSEC. Each group receives different treatments over 14 days before being sacrificed on day 15. Treatments include PBS, Lactobacillus plantarum, E. coli, and Colistin sulfate, with specific volumes and frequencies noted for each.

Figure 1. Workflow of the experiment.

2.5 Ethics statement

All experimental procedures involving animals were conducted in accordance with institutional and national guidelines for the care and use of laboratory animals. The protocol was reviewed and approved by the Animal Ethics Committee of the Animal Husbandry and Veterinary Research Institute, Fujian Academy of Agricultural Sciences (Approval No. MYLISC2024-012). All efforts were made to minimize animal stress and discomfort.

2.6 Sample collection

On day 15, ducks were fasted for 12 h and then euthanized by cervical dislocation. The thymus, spleen, liver, and bursa of Fabricius were aseptically excised, rinsed to remove surface blood, weighed, and recorded. A 1.5 cm segment of the mid-jejunum was collected, gently cleared of digesta, washed with physiological saline, and immediately fixed in 10% neutral buffered formalin for histomorphological analysis. In addition, portions of cecal contents were rapidly frozen in liquid nitrogen and stored at –80 °C for subsequent analyses.

2.7 Measurement of body weight gain and immune organ index

The body weight of each duck was recorded daily, and body weight gain was calculated accordingly. Following sample collection, the thymus, spleen, and bursa of Fabricius were excised and weighed. The relative immune organ index was calculated using the formula:

Organ index=organ weight (mg)/body weight (g)

2.8 Intestinal morphological analysis

Jejunal tissue samples were fixed in 4% (w/v) paraformaldehyde buffer for at least 48 h, dehydrated through a graded ethanol series, and cleared in xylene. The tissues were embedded in paraffin, sectioned at a thickness of 5 μm, and stained with hematoxylin and eosin (H&E). The sections were examined and photographed under a light microscope (Nikon Eclipse CI, Nikon Instruments Inc., Tokyo, Japan). Villus height and crypt depth of the jejunum were measured using CaseViewer software (version 2.0, Budapest, Hungary).

2.9 Alcian blue–periodic acid–Schiff staining

Jejunal tissue sections were stained using the Alcian blue–periodic acid–Schiff (AB-PAS) method. Fixed sections were dehydrated sequentially in graded ethanol for 2 min each, oxidized in periodic acid solution for 5 min, and rinsed in warm water for 10 min. The slides were then counterstained with Coleman’s Schiff reagent for 10 min. The stained sections were examined and photographed under a light microscope at 100× magnification.

2.10 Immunofluorescence staining

Paraffin-embedded jejunal tissue sections were deparaffinized, rehydrated, and subjected to antigen retrieval in sodium citrate buffer, followed by three washes with PBS (5 min each). The sections were then blocked with 5% bovine serum albumin (BSA; Solarbio, Beijing, China) for 30 min at room temperature. Primary antibodies against ZO-1, MUC2, and Occludin (1:500; Bioss, Beijing, China) were applied, and sections were incubated overnight at 4°C. After PBS washing, sections were incubated with FITC-conjugated secondary antibodies (1:200; Solarbio, Beijing, China) for 1 h at room temperature. Finally, nuclei were counterstained with DAPI (Solarbio, Beijing, China), and images were acquired using a fluorescence microscope (Olympus IX53, Tokyo, Japan).

2.11 Cecal microbiota sequencing

Total DNA from cecal contents was extracted using the FastDNA SPIN Kit for Feces (MP Biomedicals, Santa Ana, CA, USA). DNA concentration and purity were determined using a spectrophotometer, and integrity was assessed by agarose gel electrophoresis. The V3–V4 region of the bacterial 16S rRNA gene was amplified with universal primers 341F (5’-CCTACGGGNGGCWGCAG-3’) and 805R (5’-GACTACHVGGGTATCTAATCC-3’), and primer specificity was verified by gel electrophoresis. Purified PCR products were subjected to Illumina NovaSeq 6000 sequencing (paired-end 2 × 250 bp), with each sample generating more than 30,000 raw reads. Sequence processing followed the procedures described in our previous work (11), with additional quality control steps implemented in this study. Raw reads were imported into QIIME2 and processed with the DADA2 pipeline for quality filtering, denoising, chimera removal, and amplicon sequence variant (ASV) inference. Representative ASVs were assigned taxonomy against the SILVA 138 database. Prior to downstream analyses, feature tables were rarefied to a uniform sequencing depth. Alpha diversity (Simpson index) and beta diversity (Bray–Curtis distance, PCoA, and NMDS) were calculated in QIIME2, and differential taxa were identified using LEfSe with an LDA threshold of 3.5.

2.12 Statistical analysis

Statistical analyses were performed using one-way analysis of variance (ANOVA) in SPSS software (version 26.0; IBM, USA), followed by Tukey’s post hoc multiple comparisons to evaluate differences among groups. Graphs were generated using GraphPad Prism (version 10.4; GraphPad Software, USA). Results are expressed as mean ± standard error of the mean (SEM), with statistical significance set at P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***).

3 Results

3.1 Acid and bile salt tolerance

As shown in Figure 2A, Lactobacillus plantarum ZG-7 was able to survive under acidic conditions ranging from pH 2.0 to 4.0, with continuous growth observed up to 24 h at pH 4.0, indicating strong acid tolerance. The bile salt tolerance assay (Figure 2B) demonstrated that ZG-7 maintained growth at bile salt concentrations between 0.1% and 1.0%, with greater proliferation observed at lower concentrations, particularly within the range of 0.1%–0.3%, where growth was most pronounced.

Figure 2
Two line graphs labeled A and B show the optical density at six hundred nanometers over twenty-four hours. Graph A shows three pH levels: 2, 3, and 4. OD values increase for pH 4. Graph B displays concentration levels: 0.1%, 0.3%, 0.5%, and 1.0%. OD is highest for 0.1%. Error bars indicate variability.

Figure 2. Acid and bile salt tolerance of Lactobacillus plantarum ZG-7. (A) Growth curves of ZG-7 at different pH values (OD600); (B) Tolerance of ZG-7 to various concentrations of bile salts.

3.2 Antibacterial activity of cell-free supernatant of Lactobacillus plantarum ZG-7

As shown in Figures 3A, B, the cell-free supernatant (LP) of Lactobacillus plantarum ZG-7 exhibited significant inhibitory activity against avian pathogenic Escherichia coli O78. Moreover, the inhibitory effect was stronger at a bacterial concentration of 1 × 10^9 CFU/mL than at 1 × 10^8 CFU/mL. However, when the pH of the supernatant was adjusted to 7.0, no antibacterial activity was observed.

Figure 3
Petri dish image shows different bacterial cultures labeled LP, CON, and MRS. Adjacent bar chart depicts inhibition zone diameters for LP at concentrations of one times ten to the eighth and one times ten to the ninth. Larger inhibition for LP is indicated, with asterisks denoting statistical significance.

Figure 3. Antibacterial effect of Lactobacillus plantarum ZG-7 against E. coli O78. (A) Antibacterial activity; (B) Diameter of inhibition zones. The asterisk (*) indicates a statistically significant difference between the LP group and the CON and MRS groups (P < 0.05).

3.3 Effect of Lactobacillus plantarum ZG-7 on body weight of Muscovy ducks challenged with APEC

As shown in Figure 4, body weight of ducks significantly decreased between days 10 and 15 following E. coli challenge. Compared with the EC group, both the probiotic-treated group (LPEC) and the colistin-treated group (CSEC) exhibited significantly higher body weights during this period, with values on day 15 markedly greater than those of the EC group (P < 0.05). In addition, the CON and LP groups, which were not challenged with E. coli, also showed significantly higher body weights than the EC group; however, their weights were not significantly different from those of the LPEC and CS groups (P > 0.05). These findings indicate that L. plantarum ZG-7effectively prevented body weight loss in Muscovy ducks caused by APEC infection.

Figure 4
Line graph showing body weight in grams over 15 days for five groups: CON (pink circles), LP (blue squares), EC (yellow triangles), LPEC (green triangles), and CSEC (olive circles). All groups show an upward trend, with notable differences on Day 15, marked by asterisks.

Figure 4. Body weight change curves of Muscovy ducks. On day 15, * indicates a statistically significant difference between the LPEC group and the EC group (P < 0.05), and ** indicates a statistically significant difference between the CON group and the EC group (P < 0.01).

3.4 Effect of Lactobacillus plantarum ZG-7 on immune organ indices of Muscovy ducks challenged with APEC

As shown in Figure 5, on day 15, the spleen index of all treatment groups was lower than that of the EC group, while the bursa index was higher. Among the treatment groups, a significant decrease in spleen index compared with the EC group was observed only in the LP group (P < 0.05). No significant differences in spleen or bursa indices were detected between the EC group and the LPEC or CSEC groups (P > 0.05). These results indicate that APEC challenge markedly affected immune organ indices, while probiotic or antibiotic administration produced only limited modulatory effects within the experimental period.

Figure 5
Bar graph comparing immune organ index for spleen and bursa across different groups: CON, LP, EC, LPEC, and CSEC. Spleen index is highest for EC and lowest for LP, with a significant difference indicated. Bursa indices are similar across groups, all exceeding spleen indices. Error bars denote standard deviations.

Figure 5. Immune organ indices of Muscovy ducks. Compared with the EC group, the splenic index of the LP group showed a statistically significant difference (P < 0.05).

3.5 Effect of Lactobacillus plantarum ZG-7on intestinal morphology and goblet cells in Muscovy ducks challenged with APEC

As shown in Figure 6A, compared with the CON group, ducks in the EC group exhibited extensive inflammatory cell infiltration in the jejunal mucosa and submucosa, accompanied by epithelial cell disruption and loss of crypts and glands. Following treatment with Lactobacillus plantarum, these pathological changes were alleviated to varying degrees, with markedly reduced inflammatory infiltration and largely preserved epithelial integrity. AB-PAS staining (Figure 6B) further demonstrated that, relative to the CON group, ducks in the EC group showed a decreased number of goblet cells and reduced mucus secretion, whereas probiotic treatment increased villus length, enhanced goblet cell abundance within the mucosal epithelium, and restored production of blue-stained mucus. Quantitative analysis (Figures 6C–E) revealed that villus height was significantly reduced in the EC group (P < 0.001), crypt depth remained unchanged (P > 0.05), and the villus-to-crypt (V/C) ratio was markedly decreased (P < 0.01). In contrast, probiotic treatment significantly increased the V/C ratio (P < 0.01), suggesting a protective effect of L. plantarum ZG-7against APEC-induced jejunal damage. Consistent with these findings, higher-magnification AB-PAS images (Figure 6F) showed that probiotic treatment increased goblet cell abundance and restored mucus secretion. These results indicate that L. plantarum ZG-7effectively mitigated the loss of goblet cells caused by APEC infection.

Figure 6
Histological and graphical analysis of intestinal samples. Panel A shows H&E stained sections from five different conditions (CON, LP, EC, LPEC, CSEC) with zoomed-in views highlighting tissue morphology. Panel B presents Alcian blue-stained sections of the same conditions, with enlarged views showing goblet cells. Panels C through F display bar graphs comparing villus height, crypt depth, villus-to-crypt ratio, and goblet cell count across conditions, with significant differences indicated.

Figure 6. Jejunal morphology and goblet cell counts in Muscovy ducks. (A) H&E staining; (B) AB-PAS staining; (C) villus height; (D) crypt depth; (E) villus-to-crypt ratio (V/C); (F) goblet cell counts. Yellow arrows indicate epithelial cell damage, blue arrows indicate crypt loss, and red arrows indicate gland loss. Magnification: ×40 and ×200. In C and E, * indicates a statistically significant difference in villus height and the V/C ratio, respectively, between the EC group and each of the other groups . In F, * indicates a statistically significant difference in goblet cell counts between the EC group and each of the other groups.

3.6 Effect of Lactobacillus plantarum ZG-7 on the jejunal mucosal physical barrier of Muscovy ducks challenged with APEC

As shown in Figure 7, supplementation with Lactobacillus plantarum ZG-7 increased the expression of jejunal barrier proteins MUC2 and Occludin compared with the CON group, with Occludin showing a significant upregulation (P < 0.001). Relative to the EC group, the CSEC group exhibited significantly higher expression of ZO-1 (P < 0.01), MUC2 (P < 0.001), and Occludin (P < 0.001). Similarly, the LPEC group showed increased levels of all three proteins, with ZO-1 (P < 0.001) and Occludin (P < 0.01) significantly elevated. These results indicate that L. plantarum ZG-7 enhances the intestinal mechanical barrier and contributes to maintaining mucosal integrity. As the focus of this study was on the protective mechanisms of L. plantarum against APEC-induced intestinal injury, and our earlier results already confirmed the efficacy of colistin in alleviating intestinal damage, no further mechanistic investigations of colistin were pursued.

Figure 7
Fluorescence microscopy panels of intestinal tissue sections stained for DAPI, ZO-1, MUC2, and Occludin, with a merged view. Rows represent conditions: CON, LP, EC, LPEC, and CSEC. Bar graphs display mean densities of ZO-1, MUC2, and Occludin, showing significant differences among conditions.

Figure 7. Effect of Lactobacillus plantarum on the expression of mucin and tight junction proteins in the jejunum of APEC-infected Muscovy ducks. (A) Immunofluorescence analysis of ZO-1, MUC2, and Occludin (magnification ×40); (B) ZO-1 expression; (C) MUC2 expression; (D) Occludin expression. Blue fluorescence indicates nuclei stained with DAPI, green fluorescence indicates ZO-1, red fluorescence indicates MUC2, and yellow fluorescence indicates Occludin. In B–D, * indicates a statistically significant difference in the mean fluorescence intensity of ZO-1, MUC2, and Occludin, respectively, compared with the EC group.

3.7 Effect of Lactobacillus plantarum ZG-7 on cecal microbiota richness and diversity in Muscovy ducks challenged with APEC

To investigate changes in the intestinal microbiota, 16S rRNA gene sequencing of cecal contents was performed, and OTU numbers were analyzed to assess microbial richness. Rarefaction curves (Figure 8A) showed that when sequencing depth reached approximately 3,500 reads, the curves plateaued, indicating sufficient sequencing coverage and stable species evenness, suggesting that the sequencing depth was adequate to capture community diversity. Microbial diversity was further evaluated using the Simpson index (Figure 8B), where lower values indicate greater diversity. Results revealed that the LP group had significantly reduced microbial diversity compared with the CON, EC, and LPEC groups (P < 0.05), while no significant differences were observed among CON, EC, and LPEC groups. To further examine community composition, Bray–Curtis-based principal coordinate analysis (PCoA) and non-metric multidimensional scaling (NMDS) were conducted. As shown in Figures 8C, D, microbial communities in the CON and LPEC groups clustered closely, whereas both the LP and EC groups exhibited distinct community structures compared with the CON group.

Figure 8
Panel A shows rarefaction curves comparing Sob's index across four groups labeled CON, LP, EC, and LPEC over various numbers of reads sampled. Panel B displays a box plot for the Simpson index of OTU levels, indicating significant differences between groups, with p-values marked. Panel C presents a PCoA plot with distinct clusters for each group, highlighting variances in OTU distribution. Panel D depicts an NMDS plot, showing similar clustering patterns with stress, R-values, and significance noted. Each panel uses different colors and symbols to represent the groups.

Figure 8. Analysis of intestinal microbiota diversity in Muscovy ducks. (A) Rarefaction curves; (B) Simpson index; (C) principal coordinate analysis (PCoA) based on Bray–Curtis distances of OTUs; (D) non-metric multidimensional scaling (NMDS) based on Bray–Curtis distances of OTUs. asterisks (*) indicate statistically significant differences in the Simpson index between the indicated groups (P < 0.05).

3.8 Effect of Lactobacillus plantarum ZG-7 on intestinal microbial composition in Muscovy ducks challenged with APEC

Taxonomic classification of OTU representative sequences revealed compositional differences across treatment groups at multiple levels. Overall, the cecal microbiota of Muscovy ducks was dominated by Firmicutes, Bacteroidota, and Proteobacteria, with no significant differences among groups (P > 0.05) (Figures 9A–D). At the genus level, the predominant taxa included Unclassified Lachnospiraceae, Ruminococcus torques group, Bacteroides, Blautia, Escherichia–Shigella, Eisenbergiella, norank Eubacterium coprostanoligenes group, UC5-1-2E3, Unclassified Oscillospiraceae, Clostridia UCG-014 group, Erysipelatoclostridium, Enterococcus, Lachnospiraceae NK4A136 group, Unclassified Ruminococcaceae, Lachnoclostridium, norank RF39 group, Monoglobus, and Paludicola (Figures 9E–J). Notably, the relative abundances of Unclassified Lachnospiraceae, Lachnoclostridium, norank RF39 group, and Paludicola were significantly higher in the EC group than in the CON group (P < 0.05), whereas these taxa were markedly reduced following probiotic treatment (P < 0.05). Interestingly, the LP group showed a significantly greater abundance of Bacteroides compared with all other groups (P < 0.001).

Figure 9
Panel A and E show community bar plots depicting relative abundance of various bacterial phyla and genera in different groups (CDN, LAP, EC, UFEC). Panels B to D and F to J present bar graphs highlighting specific bacterial taxa with significant differences among these groups. Panel K is a linear discriminant analysis effect size (LEfSe) bar graph showing taxa contributing to differences. Panel L displays a cladogram illustrating taxonomic hierarchy and differences among groups. Colors differentiate groups and taxa.

Figure 9. Composition of intestinal microbiota in Muscovy ducks. (A) Cecal microbiota composition at the phylum level; (B) cecal microbiota composition at the genus level; (C) relative abundance of Firmicutes; (D) relative abundance of Bacteroidota; (E) relative abundance of Proteobacteria; (F) relative abundance of Unclassified Lachnospiraceae; (G) relative abundance of Bacteroides; (H) relative abundance of Lachnoclostridium; (I) relative abundance of norank RF39 group; (J) relative abundance of Paludicola; (K) histogram of LDA scores for microbial biomarkers in cecal microbiota; (L) cladogram of LEfSe analysis. In B and C, * indicates a statistically significant difference in the relative abundance of Firmicutes and Bacteroidota, respectively, at the phylum level compared with the EC group . In F–J, * indicates statistically significant differences in the relative abundance of unclassified Lachnospiraceae, Bacteroides, Lachnoclostridium, norank RF39 group, and Paludicola, respectively, at the phylum level compared with the EC group.

LEfSe analysis with an LDA threshold of 3.5 identified distinct microbial biomarkers among groups (Figures 9K, L). The CON group was characterized by enrichment of Firmicutes, Clostridia, Oscillospiraceae, Lachnospiraceae NK4A136 group, Candidatus Arthromitus, and Coprobacillus. The LP group was enriched in Bacteroidota, Bacteroidales, Bacteroidia, Eubacterium fissicatena group, Marvinbryantia, Ruminococcus gnavus group, and norank Oscillospiraceae. The EC group was significantly enriched in Oscillospirales, norank RF39, Paludicola, Lachnoclostridium, Leuconostoc, Eubacterium hallii group, Harryflintia, and Kosakonia. In contrast, the LPEC group exhibited enrichment of Clostridiales, Papillibacter, Clostridiaceae, norank Clostridia vadinBB60 group, and Eubacterium nodatum group. Collectively, these results indicate that LP treatment markedly altered the composition of the intestinal microbiota, reshaping the abundance of specific taxa and modulating community structure.

4 Discussion

Probiotics must possess the ability to withstand the harsh conditions of the gastrointestinal tract, including exposure to gastric acid and bile salts, which is essential for their survival and colonization. In poultry, the gastric pH typically ranges from 2.0 to 3.0, and only strains that can endure such acidic environments have the opportunity to reach the intestine and exert beneficial effects (12, 13). Bile salts, present in the avian small intestine at concentrations of 0.03%–0.30%, play a critical role in lipid emulsification and digestion; however, probiotics must also tolerate these salts in order to proliferate effectively (14). Thus, strong resistance to acidic conditions and bile salts is a defining characteristic of high-quality probiotics. In our study, Lactobacillus plantarum ZG-7 demonstrated the ability to survive and proliferate under both acidic and bile salt stress in a time-dependent manner. Importantly, the ability of probiotics to resist gastrointestinal stressors is not only a prerequisite for colonization, but also underpins their protective role against infectious diseases. Beyond its capacity to persist in the gastrointestinal tract, ZG-7 also exhibited notable antagonistic activity against pathogens, as evidenced by its significant inhibitory effect on avian pathogenic Escherichia coli (APEC).

Colibacillosis, particularly caused by APEC, represents one of the most common bacterial infections in poultry and imposes substantial economic losses on the global poultry industry (15). APEC infection not only leads to local and systemic diseases but also significantly impairs growth performance. The emergence of multidrug-resistant APEC strains has further intensified this challenge (16). As a probiotic, L. plantarum has been reported to modulate gut microbiota, enhance intestinal barrier integrity, and improve growth performance in poultry, while promoting immune responses and resistance to infection through increasing beneficial taxa and reducing pathogen colonization (8, 17). Consistent with these findings, our study showed that infection with E. coli O78 reduced body weight in ducks, whereas treatment with L. plantarum ZG-7 significantly alleviated this weight loss. These results align with previous reports demonstrating that APEC infection compromises poultry health and productivity, but supplementation with L. plantarum ZG-7can mitigate the detrimental impact of APEC on growth performance (9).

The integrity of the intestinal structure is essential for efficient nutrient absorption and overall host health. Increased villus height enhances the absorptive surface area, whereas crypt depth reflects epithelial renewal and regenerative capacity (18). Continuous migration and turnover of epithelial cells between crypts and villi are critical for maintaining barrier integrity (19). Thus, villus height, crypt depth, and the villus-to-crypt (V/C) ratio are not merely morphological indicators but comprehensive reflections of intestinal health. Previous studies have shown that E. coli infection markedly decreases villus height and the V/C ratio while increasing intestinal permeability (20). Goblet cells play a pivotal role in barrier defense through the secretion of the mucin protein MUC2, which forms a protective mucus layer against pathogen invasion and inflammation (21). For instance, supplementation with Lactobacillus reuteri in neonatal pigs increased goblet cell abundance and upregulated MUC2 expression, thereby strengthening mucosal barrier function (22). Tight junction proteins such as ZO-1 and Occludin further contribute to epithelial cohesion and barrier stability, and probiotics have been reported to enhance poultry intestinal health by modulating genes related to barrier integrity and immune function (23). In the present study, APEC infection caused severe epithelial shedding, goblet cell loss, and tight junction disruption, leading to villus atrophy, impaired morphology, and reduced nutrient absorption. Remarkably, Lactobacillus plantarum treatment mitigated these detrimental effects, partially restoring jejunal architecture and barrier function.

Beyond morphological protection, L. plantarum also exerted profound effects on the intestinal microbiota, a key determinant of digestion, immunity, and host performance in poultry. The cecal microbiota contributes to nutrient metabolism, SCFA generation, and immune modulation (2427). In our study, the LP group exhibited a significant reduction in Simpson diversity, whereas no such difference was observed among the CON, EC, and LPEC groups. Although higher α-diversity is commonly associated with intestinal health, decreased diversity does not universally indicate dysbiosis. Ducks in the LP group showed no signs of intestinal injury—villus morphology, goblet cell abundance, and tight-junction protein expression were comparable to the CON group—suggesting that the lower diversity reflected a compositional shift rather than impaired barrier function. Recent studies also indicate that probiotic-driven niche occupation can transiently lower α-diversity without compromising intestinal health (28). However, the present data do not allow determination of whether this reduction was driven by competitive niche occupation by ZG-7 or other ecological dynamics. Future studies incorporating metabolomics or metagenomic functional profiling are needed to clarify whether the LP-associated community shift corresponds to meaningful metabolic changes (17). β-diversity analyses further revealed that the microbial community structure of the LPEC group more closely resembled the CON group than the EC group, indicating that ZG-7 exerted stronger microbiota-modulating effects under APEC challenge and contributed to restoring microbial community homeostasis.

Analysis of microbial composition revealed that Firmicutes, Bacteroidota, and Proteobacteria were the dominant phyla across all groups, in line with common patterns in poultry. However, genus-level differences were more pronounced. In the EC group, Unclassified Lachnospiraceae, Lachnoclostridium, norank RF39 group, and Paludicola were significantly enriched, taxa often associated with intestinal inflammation and barrier dysfunction (29). Probiotic intervention effectively reduced their relative abundance. Conversely, the LP group displayed an increased abundance of Bacteroides, a genus often linked to polysaccharide degradation and SCFA biosynthetic potential. While this enrichment suggests altered functional potential in the microbiota, SCFA involvement cannot be inferred in the absence of direct metabolite measurements; recent poultry studies emphasize that compositional shifts do not always correspond to functional metabolic output (30). LEfSe analysis further confirmed that the EC group was enriched with inflammation-associated taxa, whereas LP supplementation promoted taxa functionally related to carbohydrate metabolism. Collectively, these findings indicate that L. plantarum ZG-7 can suppress pathogen-associated bacteria while promoting beneficial taxa under APEC challenge, thereby contributing to the restoration of intestinal microbial homeostasis.

We previously demonstrated that the cell-free supernatant of Lactobacillus plantarum ZG-7 exhibits strong antimicrobial activity and induces intestinal antimicrobial defense in Muscovy ducks (10). These findings suggest that short-term exposure to ZG-7 or its metabolites does not cause detectable intestinal toxicity in ducks. Although the present study further supports the short-term safety of ZG-7 under both healthy and APEC-challenged conditions, it does not address long-term colonization stability, potential cumulative effects, or host–microbe interactions beyond the acute phase. Therefore, additional longitudinal studies are required to evaluate whether prolonged administration of ZG-7 affects microbial ecology, immune homeostasis, or metabolic function in a sustained manner. Such investigations will be essential for determining the suitability of ZG-7 for continuous use in commercial poultry production.

Finally, although the CSEC group served as a positive control, direct comparison showed that Lactobacillus plantarum ZG-7 produced improvements in intestinal morphology and body weight similar to those of colistin sulfate. Recent evidence suggests that certain Lactobacillus strains can achieve protective efficacy comparable to antibiotics in poultry infection models (31). This supports the potential of Lactobacillus plantarum ZG-7 as a promising non-antibiotic alternative. Further studies comparing functional immune responses and microbial metabolites between probiotic and antibiotic treatments will be required to strengthen this conclusion.

5 Conclusion

This study demonstrated that Lactobacillus plantarum ZG-7 tolerates acidic and bile salt conditions, exhibits strong antibacterial activity against E. coli O78, and provides protective effects in an APEC-infected duck model. Lactobacillus plantarum ZG-7 alleviated body-weight loss, restored intestinal morphology, enhanced mucin and tight-junction protein expression, and modulated the cecal microbiota by suppressing inflammation-associated taxa and enriching beneficial Bacteroides. These findings highlight Lactobacillus plantarum ZG-7 as a promising probiotic candidate for supporting intestinal health and reducing dependence on antibiotics in poultry production.

Data availability statement

The data presented in this study have been deposited in the NCBI repository under the accession number PRJNA1400783.

Ethics statement

The animal study was approved by Animal Ethics Committee of the Animal Husbandry and Veterinary Research Institute, Fujian Academy of Agricultural Sciences (MYLISC2024-012). The study was conducted in accordance with the local legislation and institutional requirements.

Author contributions

SP: Conceptualization, Data curation, Investigation, Methodology, Software, Validation, Writing – original draft, Writing – review & editing. BX: Conceptualization, Formal analysis, Investigation, Writing – review & editing, Funding acquisition. GM: Validation, Writing – review & editing. YM: Investigation, Writing – review & editing. XL: Data curation, Writing – original draft, Investigation, Validation. MZ: Investigation, Writing – review & editing. FL: Writing – review & editing. ZL: Conceptualization, Investigation, Methodology, Writing – review & editing.

Funding

The author(s) declared that financial support was received for this work and/or its publication. This study was supported by Agricultural Guidance (Key) Project of the Fujian Provincial Department of Science and Technology (2024N0033), the Key Scientific and Technological Project of Fujian Academy of Agricultural Sciences (KJZD202404), and the Fundamental Research funds of Fujian for Public Welfare Research Institutes (2024R1063).

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2025.1701722/full#supplementary-material

References

1. Walker GK, Suyemoto MM, Gall S, Chen L, Thakur S, and Borst LB. The role of Enterococcus faecalis during co-infection with avian pathogenic Escherichia coli in avian colibacillosis. Avian Pathol. (2020) 49:589–99. doi: 10.1080/03079457.2020.1796926

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

2. Li C, Li S, Liu J, Cai H, Liu G, Deng X, et al. Escherichia coli O88 induces intestinal damage and inflammatory response through the oxidative phosphorylation and ribosome pathway in Pekin ducks. Front Cell Infect Microbiol. (2022) 12:940847. doi: 10.3389/fcimb.2022.940847

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

3. Roth N, Hofacre C, Zitz U, Mathis GF, Moder K, Doupovec B, et al. Prevalence of antibiotic-resistant E. coli in broilers challenged with a multi-resistant E. coli strain and received ampicillin, an organic acid-based feed additive or a synbiotic preparation. Poult Sci. (2019) 98:2598–607. doi: 10.3382/ps/pez004

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

4. Kathayat D, Closs G Jr., Helmy YA, Deblais L, Srivastava V, and Rajashekara G. In Vitro and In Vivo Evaluation of Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis Bb12 Against Avian Pathogenic Escherichia coli and Identification of Novel Probiotic-Derived Bioactive Peptides. Probiotics Antimicrob Proteins. (2022) 14:1012–28. doi: 10.1007/s12602-021-09840-1

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

5. Liu Y, Liu G, and Fang J. Progress on the mechanisms of Lactobacillus plantarum to improve intestinal barrier function in ulcerative colitis. J Nutr Biochem. (2024) 124:109505. doi: 10.1016/j.jnutbio.2023.109505

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

6. Zhang F, Li Y, Wang X, Wang S, and Bi D. The impact of lactobacillus plantarum on the gut microbiota of mice with DSS-induced colitis. BioMed Res Int. (2019) 2019:3921315. doi: 10.1155/2019/3921315

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

7. Jang SE, Jeong JJ, Kim JK, Han MJ, and Kim DH. Simultaneous Amelioratation of Colitis and Liver Injury in Mice by Bifidobacterium longum LC67 and Lactobacillus plantarum LC27. Sci Rep. (2018) 8:7500. doi: 10.1038/s41598-018-25775-0

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

8. Wang S, Peng Q, Jia HM, Zeng XF, Zhu JL, Hou CL, et al. Prevention of Escherichia coli infection in broiler chickens with Lactobacillus plantarum B1. Poult Sci. (2017) 96:2576–86. doi: 10.3382/ps/pex061

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

9. Mirsalami SM and Mirsalami M. Leveraging Lactobacillus plantarum probiotics to mitigate diarrhea and Salmonella infections in broiler chickens. AMB Express. (2024) 14:137. doi: 10.1186/s13568-024-01792-3

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

10. Li Z, Guo Q, Lin F, Li C, Yan L, Zhou H, et al. Lactobacillus plantarum supernatant inhibits growth of Riemerella anatipestifer and mediates intestinal antimicrobial defense in Muscovy ducks. Poult Sci. (2024) 103:103216. doi: 10.1016/j.psj.2023.103216

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

11. Peng S, Lu X, Lin F, Mao N, Yu L, Zhu T, et al. Rosa laevigata Polysaccharides Ameliorate Dextran Sulfate Sodium-Induced Ulcerative Colitis of Beagles through Regulating Gut Microbiota. Chem Biodivers. (2024) 21:e202302102. doi: 10.1002/cbdv.202302102

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

12. Ahmed Z, Vohra MS, Khan MN, Ahmed A, and Khan TA. Antimicrobial role of Lactobacillus species as potential probiotics against enteropathogenic bacteria in chickens. J Infect Dev Ctries. (2019) 13:130–6. doi: 10.3855/jidc.10542

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

13. Benbara T, Lalouche S, Drider D, and Bendali F. Lactobacillus plantarum S27 from chicken faeces as a potential probiotic to replace antibiotics: in vivo evidence. Benef Microbes. (2020) 11:163–73. doi: 10.3920/BM2019.0116

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

14. Shahbaz F, Muccee F, Shahab A, Safi SZ, Alomar SY, and Qadeer A. Isolation and in vitro assessment of chicken gut microbes for probiotic potential. Front Microbiol. (2024) 15:1278439. doi: 10.3389/fmicb.2024.1278439

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

15. Aberkane C, Messai A, Messai CR, and Boussaada T. Antimicrobial resistance pattern of avian pathogenic Escherichia coli with detection of extended-spectrum beta-lactamase-producing isolates in broilers in east Algeria. Vet World. (2023) 16:449–54. doi: 10.14202/vetworld.2023.449-454

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

16. Dhaouadi S, Soufi L, Hamza A, Fedida D, Zied C, Awadhi E, et al. Co-occurrence of mcr-1 mediated colistin resistance and beta-lactamase-encoding genes in multidrug-resistant Escherichia coli from broiler chickens with colibacillosis in Tunisia. J Glob Antimicrob Resist. (2020) 22:538–45. doi: 10.1016/j.jgar.2020.03.017

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

17. Yin Y, Liao Y, Li J, Pei Z, Wang L, Shi Y, et al. Lactobacillus plantarum GX17 benefits growth performance and improves functions of intestinal barrier/intestinal flora among yellow-feathered broilers. Front Immunol. (2023) 14:1195382. doi: 10.3389/fimmu.2023.1195382

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

18. Chen Z, Yan Z, Xia S, Wang K, Han Q, Zhou M, et al. Dietary isatidis root residue improves diarrhea and intestinal function in weaned piglets. Anim (Basel). (2024) 14:2776. doi: 10.3390/ani14192776

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

19. Kai Y. Intestinal villus structure contributes to even shedding of epithelial cells. Biophys J. (2021) 120:699–710. doi: 10.1016/j.bpj.2021.01.003

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

20. Li P, Zhao S, Teng Y, Han S, Yang Y, Wu M, et al. Dietary supplementary with ellagic acid improves the intestinal barrier function and flora structure of broiler chicken challenged with E. coli K88 Poult Sci. (2024) 103:104429. doi: 10.1016/j.psj.2024.104429

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

21. Shan M, Gentile M, Yeiser JR, Walland AC, Bornstein VU, Chen K, et al. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science. (2013) 342:447–53. doi: 10.1126/science.1237910

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

22. Wang M, Wu H, Lu L, Jiang L, and Yu Q. Lactobacillus reuteri promotes intestinal development and regulates mucosal immune function in newborn piglets. Front Vet Sci. (2020) 7:42. doi: 10.3389/fvets.2020.00042

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

23. Gharib-Naseri K, de Paula Dorigam JC, Doranalli K, Kheravii S, Swick RA, Choct M, et al. Modulations of genes related to gut integrity, apoptosis, and immunity underlie the beneficial effects of Bacillus amyloliquefaciens CECT 5940 in broilers fed diets with different protein levels in a necrotic enteritis challenge model. J Anim Sci Biotechnol. (2020) 11:104. doi: 10.1186/s40104-020-00508-4

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

24. Ma L, Lyu W, Zeng T, Wang W, Chen Q, Zhao J, et al. Duck gut metagenome reveals the microbiome signatures linked to intestinal regional, temporal development, and rearing condition. Imeta. (2024) 3:e198. doi: 10.1002/imt2.198

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

25. Oakley BB, Lillehoj HS, Kogut MH, Kim WK, Maurer JJ, Pedroso A, et al. The chicken gastrointestinal microbiome. FEMS Microbiol Lett. (2014) 360:100–12. doi: 10.1111/1574-6968.12608

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

26. Kogut MH, Lee A, and Santin E. Microbiome and pathogen interaction with the immune system. Poult Sci. (2020) 99:1906–13. doi: 10.1016/j.psj.2019.12.011

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

27. Pan D and Yu Z. Intestinal microbiome of poultry and its interaction with host and diet. Gut Microbes. (2014) 5:108–19. doi: 10.4161/gmic.26945

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

28. Peng Q, Zeng XF, Zhu JL, Wang S, Liu XT, Hou CL, et al. Effects of dietary Lactobacillus plantarum B1 on growth performance, intestinal microbiota, and short chain fatty acid profiles in broiler chickens. Poult Sci. (2016) 95:893–900. doi: 10.3382/ps/pev435

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

29. Wang B, Zhou Y, Mao Y, Gong L, Li X, Xu S, et al. Dietary Supplementation With Lactobacillus plantarum Ameliorates Compromise of Growth Performance by Modulating Short-Chain Fatty Acids and Intestinal Dysbiosis in Broilers Under Clostridium perfringens Challenge. Front Nutr. (2021) 8:706148. doi: 10.3389/fnut.2021.706148

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

30. Fan Y, Ju T, Bhardwaj T, Korver DR, and Willing BP. Week-old chicks with high bacteroides abundance have increased short-chain fatty acids and reduced markers of gut inflammation. Microbiol Spectr. (2023) 11:e0361622. doi: 10.1128/spectrum.03616-22

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

31. Naeem M and Bourassa D. Probiotics in poultry: unlocking productivity through microbiome modulation and gut health. Microorganisms. (2025) 13:257. doi: 10.3390/microorganisms13020257

PubMed Abstract | PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: Lactobacillus plantarum ZG-7, avian pathogenic Escherichia coli, intestinal barrier, cecal microbiota, Muscovy duck

Citation: Peng S, Xie B, Mei G, Ma Y, Lin X, Zhao M, Lin F and Li Z (2026) Effects of Lactobacillus plantarum ZG-7 on the intestinal barrier and intestinal flora of Muscovy ducks infected with avian pathogenic Escherichia coli. Front. Immunol. 16:1701722. doi: 10.3389/fimmu.2025.1701722

Received: 09 September 2025; Accepted: 11 December 2025; Revised: 19 November 2025;
Published: 16 January 2026.

Edited by:

Vijay Morampudi, University of Hyderabad, India

Reviewed by:

Gelana Urgesa Ayana, Jimma University, Ethiopia
Seyed Mehrdad Mirsalami, University of Guilan, Iran

Copyright © 2026 Peng, Xie, Mei, Ma, Lin, Zhao, Lin and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zhaolong Li, NDk3Mzc3NTEyQHFxLmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.